KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer by Ahmad, Aamir et al.
RESEARCH ARTICLE
KIAA1199 promotes migration and invasion
by Wnt/β-catenin pathway and MMPs
mediated EMT progression and serves as a
poor prognosis marker in gastric cancer
Shuqin Jia1,2☯*, Tingting Qu2☯, Xiaohong Wang3, Mengmeng Feng1, Yang Yang1,
Xuemin Feng1, Ruiting Ma1, Wenmei Li2, Ying Hu3, Yi Feng2, Ke Ji4, Ziyu Li4,
Wenguo Jiang5, Jiafu Ji4*
1 Laboratory of Surgery, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China, 2 Center
for Molecular Diagnosis, Key Laboratory of Carcinogenesis and Translational Research (Ministry of
Education), Peking University Cancer Hospital & Institute, Beijing, China, 3 Tissue Bank, Key Laboratory of
Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital &
Institute, Beijing, China, 4 Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and
Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China,
5 Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, United
Kingdom
☯ These authors contributed equally to this work.
* jiashuqin2014@163.com (SQJ); jijiafu@hsc.pku.edu.cn (JFJ)
Abstract
Background
KIAA1199 was upregulated in diverse cancers, but the association of KIAA1199 with gastric
cancer (GC), the biological role of KIAA1199 in GC cells and the related molecular mecha-
nisms remain to be elucidated.
Methods
KIAA1199 expression was analysed by reverse transcription-polymerase chain reaction
assay (RT-PCR) and immunohistochemistry (IHC) in GC patient tissue. The small hairpin
RNA (shRNA) was applied for the knockdown of endogenous KIAA1199 in NCI-N87 and
AGS cells. MTT, colony formation, scratch wounding migration, transwell chamber migra-
tion and invasion assays were employed respectively to investigate the role of KIAA1199 in
GC cells. The potential signaling pathway of KIAA1199 induced migration and invasion was
detected.
Results
KIAA1199 was upregulated in GC tissue and was an essential independent marker for poor
prognosis. Knockdown KIAA1199 suppressed the proliferation, migration and invasion in
GC cells. KIAA1199 stimulated the Wnt/β-catenin signaling pathway and the enzymatic
activity of matrix metalloproteinase (MMP) family members and thus accelerated the epithe-
lial-to-mesenchymal transition (EMT) progression in GC cells.
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Conclusion
These findings demonstrated that KIAA1199 was upregulated in GC tissue and associated
with worse clinical outcomes in GC, and KIAA1199 acted as an oncogene by promoting
migration and invasion through the enhancement of Wnt/β-catenin signaling pathway and
MMPs mediated EMT progression in GC cells.
Introduction
Gastric cancer (GC) is one of the most lethal malignancies and the third leading cause of can-
cer-related mortality [1]. Thus, there is an urgent need to improve our depth of understanding
on the clinical biomarkers and the molecular underpinnings that drive GC initiation, progres-
sion and metastasis. Because metastasis is a major factor responsible for poor prognosis in GC,
the identification of novel molecular markers of a metastatic phenotype is a crucial challenge
in GC therapy [2,3].
KIAA1199 was overexpressed in diverse cancers, such as colon cancer, breast cancer and
oral squamous cell carcinoma [4–7]. The abnormal expression of molecules usually triggered a
series of malignant biological initiations. In breast cancer, the expression of KIAA1199 was
demonstrated to be especially upregulated in invasive breast cancer specimens and cell lines by
large scale microarray and studies of breast cancer cell lines, which indicated that KIAA1199
was associated with cell proliferation, motility and apoptosis [5,8]. The role of KIAA1199 in
colon cancer was extensively elucidated in recent studies. KIAA1199 had been identified not
only to be associated with clinicopathological parameters and 5 year-overall survival rate in
colon cancer but also as an essential inducer for cell proliferation, migration and invasion by
complex signaling pathways[9–11]. Proteomics analysis by two-dimensional gel electrophore-
sis and mass spectrometry assay revealed KIAA1199 was one novel protein that expressed
abnormally in oral cancer, which was then demonstrated by Realtime-PCR assay [6]. Further-
more, the latest report also indicated KIAA1199 as a newly identified protein which probably
played significant role in pancreatic ductal adenocarcinoma [7]. Besides, over expression of
KIAA1199 was also detected in GC by Chivou et al and Matsuzaki et al [12,13]. Whereas, fur-
ther research on KIAA1199 in GC was rarely reported and how the KIAA1199 affected GC
progression was still unknown.
In this study, the expression of KIAA1199 in GC patient tissues verified thatKIAA1199 was
associated with the depth of invasion, distant metastasis and the overall survival rate in GC
patients. Furthermore, on the basis of clinicopathological parameters analysis, two selected GC
cell lines were utilized to validate that KIAA1199 was involved in the malignant biological pro-
gression including cell proliferation, especially more dominant in cell migration and invasion.
Finally, we elucidated that the molecular mechanism of KIAA1199 on GC cell migration and
invasion was related to the EMT progression which induced by Wnt/β-catenin signaling path-
way and the activation of MMPs.
Materials and methods
Patients and gastric tissue specimens
A total of 321 paraffin-embedded and 123 paraffin-sectioned gastric cancer tissues were col-
lected from GC patients from Peking University Cancer Hospital between 1998 and 2008. Fur-
thermore, 15 surgically removed frozen GC samples in 2014 were obtained from the BioBank
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of Peking University Cancer Hospital. Some patients received chemotherapy or radiation ther-
apy before surgery. All human samples were obtained through written informed consent from
patients and the ethics committee of Peking University Cancer Hospital approved these tissues
for research use. The following clinicopathological information was obtained from patient
data. GC staging was classified according to 1997 Union for international cancer control
(UICC)-TNM criteria.
Immunohistochemistry
For immunohistochemistry, 4 μm-thick sections cut from the FFPE tissue blocks were depar-
affinized and rehydrated using xylene and a graded ethanol washes. Antigen retrieval was per-
formed in 10mmol sodium citrate buffer (pH 6.0) for 20 minutes, and endogenous peroxidase
activity was blocked with 3% hydrogen peroxide for 15 minutes. The sections were then
blocked with normal sheep serum at room temperature for 90minutes, and incubated with
KIAA1199 Abcam antibody (Abcam, ab-76849) diluted at 1:100 overnight at 4˚C. The sections
were incubated at room temperature for 1 hour with the secondary antibody and then were
incubated with peroxidase substrate solution. Finally, the sections were counterstained with
hematoxylin followed by being dehydrated in ethanol and cleared with xylene. GC specimens
were defined as KIAA1199-negative expression when less than 20% cancer cells were stained
or KIAA1199-positive expression when 20% or more cancer cells were stained. Negative con-
trol was prepared by substituting PBS for the primary antibody.
Cell lines and cell culture
All the GC cell lines were provided by the Peking University Cancer Hospital & Institute.
SGC-7901, BGC-803, NCI-N87 and AGS cell lines were cultured in Dulbecco’s modified Eagle
medium (DMEM; MAC GENE) supplemented with 10% fetal bovine serum (FBS; HyClone)
and BGC-823 cell line was cultured in DMEM supplemented with 5% FBS. All the cell lines
were maintained at 37˚C, 5%CO2.
RNA interference
The small hairpin RNA (shRNA) was used for the knockdown of endogenous KIAA1199 in
NCI-N87 and AGS cells. The target sequence was from the previous published paper [14]. The
target sequence was: 5’-CGAATGAAGATCATCAAGAAT-3’, and GV248 was used as sh-con-
trol. Cells with depleted endogenous KIAA1199 expression were selected by being cultured in
puromycin at the final selection concentration of 2μg/ml.
RNA extraction and RT-PCR
Total RNA was extracted from tissue samples and cell lines using the Trizol reagent
(Ambion,15596–026) according to the manufacturer’s instructions. Reverse transcription-
polymerase chain reaction was used to determine the mRNA level of KIAA1199 in the gastric
carcinoma tissue and its adjacent noncancerous tissue. GAPDH was used as a control. PCR
was performed in PCR reaction mix with initial heating at 94˚C for 5 minutes, followed by 30
cycles of 94˚C for 30 seconds, 60˚C for 30 seconds and 72˚C for 30seconds, then with a final
extension step of 72˚C for 10 minutes. The primers for KIAA1199 were KIAA1199, for
ward: TGCCACGGTCTATTCCATC, reverse:TCCTTTACCAACCCCAATG; The prim
ers for GAPDH were GAPDH,forward:GCATCCTGGGCTACACT,reverse:
CACCACCCTGTTGCTGT.
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Quantitative real-time PCR
Quantitative real-time PCR was performed with the ABI PRISM 7500 Sequence Detection Sys-
tem using the SYBR Green method. The mRNA levels of all detected genes were normalized to
GAPDH. Specific primers used in PCR amplification were as follows: KIAA1199,for
ward: TGCCACGGTCTATTCCATC, reverse:TCCTTTACCAACCCCAATG; β-cate
nin, forward:ACGGAGGAAGGTCTGAGGAG,reverse:AGCCGCTTTTCTGTCTGGTT;
c-Myc,forward:TGGTCTTCCCCTACCCTCTCAAC, reverse:GATCCAGACTCT
GACCTTTTGCC;cyclinD1,forward:GATGCCAACCTCCTCAACGA,reverse:
GGAAGCGGTCCAGGTAGTTC;MMP2, forward:AGTTTCCATTCCGCTTCCAG,
reverse:CGGTCGTAGTCCTCAGTGGT;MMP7, forward:CATGATTGGCTTTGCGC
GAG, reverse:AGACTGCTACCATCCGTCCA;MMP9, forward:CCAACTACGACACC
GACGAC,reverse:TGGAAGATGAATGGAAACTGG; MMP14,forward:AGCCATA
TTGCTGTAGCCAG,reverse:GTTGTCTCCTGCTCCCCCT; Slug, forward:CTAC
AGCGAACTGGACACACA,reverse:GCCCCAAAGATGAGGAGTATC;Snail, forward:
TCCAGAGTTTACCTTCCAGCA,reverse:CTTTCCCACTGTCCTCATCTG; Twist,for
ward: GTCCGCAGTCTTACGAGGAG, reverse:GTCTGAATCTTGCTCAGCTTGTC;
Vimentin,forward:GGACCAGCTAACCAACGACA,reverse:AAGGTCAAGACGTGC
CAGAG;GAPDH, forward:GCATCCTGGGCTACACT,reverse:
CACCACCCTGTTGCTGT.
Western blotting
Cells were lysed completely in lysis buffer (50mM Hepes pH7.5, 150mM NaCl, 2mM EDTA,
2mM EGTA, 1% TritonX-100, 50mM NaF, 5mM Sodiun Pyrophosphate, 50mM Sodium β-
glycerophosphate, 1mM DTT, 1mM PMSF, 10μg/ml Leupeptin, 10μg/ml Aprotinin) at 4˚C.
The protein content was determined using a BCA Protein Assay Kit (Thermo, USA). Total
proteins were separated by SDS-PAGE and then transferred onto PVDF membranes (Milli-
pore, USA). The blotted membranes were incubated with primary antibodies and then with
corresponding secondary antibody of the primary antibody. Antibody against GAPDH (Santa
Cruz, sc-166545) was purchased from Santa Cruz. The KIAA1199 (Proteintech, 21129-1-AP)
antibody and Lamin B1 (Proteintech, 66095-1-Ig) antibody were purchased from Proteintech.
The β-cateninantibody was provided by Division of Gastrointestinal Cancer Translational
Research Laboratory (Peking University Cancer Hospital & Institute).
Cytoplasm and nuclear extraction
1×107 cells were prepared and washed with PBS for twice. The cell pellets were resuspended
gently in 300 μl CER I (10mM Hepes pH7.9, 1.5mM MgCl2, 10%glycerol, 10mM KCl, 0.34M
sucrose, 0.5mM DTT, 1mM PMSF, 10μg/ml Leupeptin, 10μg/ml Aprotinin) before being vor-
texed vigorously for 20 seconds and was then left on ice for 10 minutes. After the addition of
NP-40 at the final concentration of0.3%, the cell resuspension was vortexed again vigorously
for 10 seconds and was left on ice for 1 minute, and such step was repeated for thrice followed
by centrifugation at 12000 rpm for 10 minutes. The supernatants were then collected as the
cytoplasmic extraction. The pellets were suspended with 60 μl lysis buffer (50mM Hepes
pH7.5, 150mM NaCl, 2mM EDTA, 2mM EGTA, 1% TritonX-100, 50mM NaF, 5mM Sodiun
Pyrophosphate, 50mM Sodium β-glycerophosphate, 1mM DTT, 1mM PMSF, 10μg/ml Leu-
peptin, 10μg/ml Aprotinin) before being vortexed for 20 seconds and was then left on ice for
10 minutes, and this step was repeated for quartic. Finally, the lysate was centrifuged at 12000
rpm for 10 minutes and supernatants were collected as the nuclear extraction.
Biological role of KIAA1199 in migration and invasion in gastric cancer
PLOS ONE | https://doi.org/10.1371/journal.pone.0175058 April 19, 2017 4 / 16
Cell proliferation assay
The MTT assay was performed to assess cell proliferative activity. NCI-N87 and AGS cells
were seeded into 96-well plates at 1×103 per well and incubated at 37˚C with 5% CO2 for 24
hours, 48 hours, 72 hours and 96 hours. At the detection time points, MTT solution was added
to each well and the plates were incubated for another 4 hours. The formazan crystals were
then dissolved with 100 μl dimethyl sulfoxid per well. The absorbance of at least 3 individual
wells of one cell type at each time point was read using a microplate reader (Bio-Rad, USA).
Colony formation
For colony formation assay, 500 of NCI-N87 and AGS cells were seeded in triplicate in 60-mm
dishes. After appropriate time of growth, the cells were washed with PBS for three times fol-
lowed by being fixed with 4% paraformaldehyde for 20 minutes. The cells were then stained
with 0.1% crystal violet for 20 minutes, and were finally washed with PBS for three times. Pho-
tographs were captured and the numbers of the cell clones in 3 independent samples were
counted.
Scratch wounding migration assay
Scratch wounding migration assay was detected by the IncuCyte HD system (IncuCyte
ZOOM, Essen BioScience, USA). NCI-N87 and AGS cells were grown in 96-well culture plates
until the formation of a monolayer. Cell layers were scraped with a pin block and then incu-
bated at 37˚C. Photographs were captured at set time points by IncuCyte HD system. The
migration distance was measured at each time point in 3 independent samples.
Transwell chamber migration and invasion assay
Transwell chamber migration assay was measured using a transwell chamber with 8μm filter
inserts (BD Biosciences, USA) without Matrigel. For transwell chamber-based invasion assay,
transwell inserts with 8 μm filter were pre-coated with 50 μg of Matrigel (Becton Dickinson,
San Jose, CA).5×104 cells were added to the inserts containing serum-free DMEM medium.
The lower chamber was filled with 600 μl DMEM medium with 10% FBS. After 24 hours’ incu-
bation for AGS cells (migration and invasion) and 48 hours’ (migration) or 72 hours’ (inva-
sion) incubation of NCI-N87 cells, the inside of the inserts was cleaned thoroughly with a
cotton swab to remove any non-migrated or non-invasive cells, and the cells which had
migrated through the porous membrane and invaded into the Matrigel were fixed with 4%
paraformaldehyde for 20 minutes, and were then stained with 0.1% crystal violet for 20 min-
utes. Photographs were captured and the migrated cells were counted in at least 3 random
fields.
Statistical analysis
The association of KIAA1199 mRNA and protein expression with clinicopathological features
in GC patients was analysed by Chi-square test and Kruskal-Wallis test. Cox regression analy-
sis was utilized to estimate the relative risks of death associated with KIAA1199 protein expres-
sion. The overall survival curve was analysed by the Kaplan-Meier method. Other data were
analysed using Student’s t-test. Statistical analysis was carried out using the SPSS 21.0 software
(SPSS Inc., Chicago, IL, USA). All data were represented as mean value ± S.D. A two-tailed
P< 0.05 was considered statistically significant.
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Results
KIAA1199 is frequently overexpressed in primary GC
RT-PCR was applied for semi-quantitative analysisonKIAA1199 mRNA expression in primary
GC. Initial screening of surgically resected CGs from 15 patients revealed that KIAA1199 was
upregulated in 13 cases (Fig 1A). To further confirm this result, we also examined the protein
expression of KIAA1199 in primary GC by immunohistochemistry (IHC) with an anti-
KIAA1199 antibody. As shown in Fig 1B, KIAA1199 was seldom expressed in adjacent non-
cancerous tissue, but was highly expressed in the cytoplasm of GC tissue cells.
Association of KIAA1199 expression level with clinicopathological
parameters in GC patients
To investigate the clinical role of KIAA1199 in GC, we assessed the correlations between
KIAA1199 expression and clinicopathological parameters, including sex, depth of invasion (T-
staging), lymph node status, distant metastasis (M-staging), TNM staging, tumor differentia-
tion and clinical outcome of GC patients. We first utilized Realtime-PCR to detect the
KIAA1199 mRNA expression in 321 GC patient tissues. As shown in Table 1, statistical analy-
sis showed that KIAA1199 mRNA expression was correlated with the clinical characteristics
regarding depth of invasion (T-staging), distant metastasis (M-staging) and TNM staging (T-
staging: P<0.001; M-staging: P<0.05; TNM: P<0.001) of GC patients. The protein expression
of KIAA1199 was also detected by IHC. The IHC analysis on the biopsies from123 GC patients
showed that KIAA1199 protein expression had no significant effect on such clinical parame-
ters regarding age, sex, vascular invasion and differentiation, but was correlated with depth of
invasion, lymph node status (N-staging), metastasis and TNM staging (T-staging: P<0.01; N-
staging: P<0.01; M-staging: P<0.05; TNM: P<0.01), which was mostly consistent with the
KIAA1199 mRNA expression clinical characteristics analysis in GC patients (Table 2). As
shown in Table 3, the multivariate analysis of overall survival (OS) indicated that KIAA1199
expression was an essential independent marker for poor prognosis (P<0.01). Kaplan-Meier
survival curves showed that the OS of the patients with KIAA1199 expression was worse com-
pared to the patients with no expression of KIAA1199 in GC (P<0.001, Fig 1C).
Knockdown KIAA1199 reduced cellular proliferation in GC cells
In order to explore the role of KIAA1199 in gastric cancer cell proliferation, we assessed the
KIAA1199 expression level in five gastric cancer cell lines (Fig 2A) and utilized a loss of func-
tion approach in two KIAA1199 high expression GC cell types—NCI-N87 and AGS. The
KIAA1199 expression of two selected GC cell lines which infected with a lentivirus expressing
anti-KIAA1199 small hairpin RNA (shRNA) were confirmed by Realtime-PCR and Western
blotting (Fig 2B). The effect of KIAA1199 on the proliferation of two GC cell lines was exam-
ined through MTT assay and clone formation assay. As shown in Fig 2C and 2D, both of these
two assays revealed that KIAA1199 knockdown suppressed the proliferation of NCI-N87 and
AGS cells compared to their respective sh-control cells (P<0.01).
KIAA1199 promoted both GC cell migration and invasion
Migration and invasion are proved as two essential factors which accelerate the malignant bio-
logical occurrence. The occurrence of these two malignant biological processes is usually
accompanied by some clinicopathological parameters changes. Since KIAA1199 expression
was significantly associated with depth of invasion (T3+T4 staging) and distant metastasis (M1
staging) in patients with GC, it was likely that KIAA1199 played important roles in GC cell
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migration and invasion. As expected, scratch wounding and transwell chamber migration
assays exhibited that the downregulation of KIAA1199 inhibited GC cells migration
(NCI-N87, scratch wounding assay: P<0.01, transwell chamber migration assay: P<0.01;
AGS, scratch wounding assay: P<0.05, transwell chamber migration assay: P<0.01)(Fig 2E
and 2F). Furthermore, the effect of KIAA1199 on GC cell invasion was also investigated. As
shown in Fig 2G, the invasive ability was impaired in sh-KIAA1199 GC cells compared to that
of in sh-control cells (NCI-N87, P<0.01; AGS, P<0.001) in transwell chamber invasion assay.
KIAA1199induced EMT progression by upregulatingWnt/β-catenin
signaling and MMPs in GC cells
To further investigate the mechanism of KIAA1199 induced GC cell invasion and metastasis,
we examined some pathways that are involved in cell invasion and metastasis. As shown in Fig
Fig 1. KIAA1199 expression in primary GC tissues and survival curve for KIAA1199 expression in patients
with GC. (A)The mRNA expression of KIAA1199 in adjacent noncancerous tissue and GC samples by RT-PCR. (B)
KIAA1199 expression by immunohistochemical staining. N: adjacent noncancerous tissue; T: gastric cancer tissue.
Original magnification: 200× and 400×. (C) Kaplan-Meier survival curves analysis of overall survival for all patients
with KIAA1199 negative and positive GC tissue.
https://doi.org/10.1371/journal.pone.0175058.g001
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3A, knockdown of KIAA1199 reduced β-catenin expression in NCI-N87 and AGS cells. The
decreased expression of β-catenin abolished itself accumulation in cytoplasm which caused
less β-catenin to enter the nucleus (Fig 3B), thus inhibited the initiation of Wnt/β-catenin sig-
naling pathway. Therefore, we also detected the expression of two main downstream target
genes involved in Wnt/β-catenin signaling pathway. As shown in Fig 3C, the expression of c-
myc and cyclinD1 were both decreased, especially cyclinD1. According to this result, we pro-
posed that KIAA1199 was possibly associated with invasion and metastasis through Wnt/β-
catenin signaling pathway.
The EMT is one of the major complex processes mediated by Wnt/β-catenin signaling path-
way which plays important role in cancer invasion and metastasis [15,16]. The inducers which
have been demonstrated to be involved in EMT initiation during cancer progression and
metastasis can be classified as cellular factors, transcriptional factors and matrix metalloprotei-
nases. The EMT-related molecules were detected in Fig 3D, and the mRNA expression of Snail
and Vimentin were decreased by KIAA1199 knockdown in NCI-N87 cells (P<0.05). Addi-
tionally, the mRNA expression levels of four typical EMT-related molecules were all decreased
significantly (Slug, P<0.05; Snail, P<0.01; Vimentin, P<0.05; Twist, P<0.01) in AGS cells.
Furthermore, MMP family, which has previously been shown to induce EMT in variety of can-
cer, was also detected in Fig 3E. The results revealed that except for MMP9, the expression of
MMP2, MMP7 and MMP14 were suppressed in KIAA1199 knockdown NCI-N87 and AGS
cells(NCI-N87: MMP2, MMP7,MMP14, P<0.05; AGS: MMP2, P<0.05; MMP7,MMP14,
P<0.01).
Table 1. Relationship between KIAA1199 mRNA expression and clinicopathological features in patients with GC.
Clinicopathological Features Cases KIAA1199 expression P
Median (Q1, Q3)
Gender
Male 229 58.86(4.36–90.64) 0.616
Female 92 50.00(3.50–59.60)
Depth of invasion
T1-2 42 37(3.19–30.60) 0.000
T3-4 271 19(4.39–96.85)
Lymph node status
N0 69 22.2(4.5–100.1) 0.46a
N1-3 246 20.05(4.28–86.95
Distant metastasis
M0 272 20(4.44–82.63) 0.028
M1 40 35.6(3.50–104.90)
TNM staging
TNM1-2 84 19.2(4.4–65.1) 0.000
TNM3-4 228 20.76(4.35–91.39)
Differentiation
High-medium 6 31.9(14.6–72.8)
Medium 62 10.6(3.8–87.6) 0.09b
Medium-low 82 39.4(7.6–142.8) 0.002b
Low 136 14.3(3.2–51.1) 0.199b
a Compared with “N0”.
b Compared with “High-medium”.
https://doi.org/10.1371/journal.pone.0175058.t001
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Discussion
In order to identify new biomarkers for the improvement of diagnosis strategies and targeted
therapies, better understand biology and the molecular profiles of GC is an essential work. In
this study, we first examined the mRNA and protein expression levels of KIAA1199 by
RT-PCR and immunohistochemistry in 15 surgically resected GC cases and 123 paraffin sec-
tion samples (1997–2008) respectively. The results indicated that KIAA1199 was strongly
expressed in GC tumors in comparison to normal gastric tissue. Based on these data, we also
verified the KIAA1199 mRNA and protein expression in 321 cases (2004–2007) and 123 cases
of GC patients by Realtime-PCR and immunohistochemistry respectively to further investigate
the association of KIAA1199 expression with clinicopathological parameters changes. Statisti-
cal analysis showed that KIAA1199 expression was not significantly correlated with such clini-
cal parameters regarding age, sex, vascular invasion and pathological differentiation degrees
(P>0.05). Interestingly, significant correlations were observed between KIAA1199 expression
Table 2. Relationship between KIAA1199 protein expression and clinicopathological features in patients with GC.
Clinicopathological Features Cases KIAA1199 expression χ2 P a
Negative (%) Positive (%)
Gender
Male 78 30(38.5%) 48(61.5%) 0.792 0.374
Female 45 21(46.7%) 24(53.3%)
Age (years)
60 57 28(49.1%) 29(50.9%) 2.568 0.109
>60 66 23(34.8%) 43(65.2%)
Vascular invasion
Absent 44 23(52.3%) 21(47.7%) 3.546 0.06
Present 75 26(34.7%) 49(65.3%)
Depth of invasion
T1-2 34 22(64.7%) 12(35.3%) 10.458 0.001
T3-4 89 29(32.6%) 60(67.4%)
Lymph node status
N0 29 19(65.5%) 10(34.5%) 9.046 0.003
N1-3 94 32(34.0%) 62(66.0%)
Distant metastasis
M0 109 49(45.0%) 60(55.0%) 4.808 0.028
M1 14 2(14.3%) 12(85.7%)
TNM staging
I 9 5(55.6%) 4(44.4%) 16.463 0.001b
II 25 18(72.0%) 7(28.0%)
III 78 27(34.6%) 51(65.4%)
IV 11 1(9.1%)) 10(90.9%)
Differentiation
High 0 0(0.0%) 3(100.0%) 6.058 0.195
High-medium 5 1(20.0%) 4(80.0%)
Medium 17 8(47.1%) 9(52.9%)
Medium-low 27 8(29.6%) 19(70.4%)
Low 71 34(47.9%) 37(52.1%)
a Chi-square test,
b Kruskal-Wallis test.
https://doi.org/10.1371/journal.pone.0175058.t002
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and depth of invasion, lymph node status, distant metastasis and TNM staging of GC patients.
The statistical analysis on the relationship between these two main meaningful expression lev-
els of KIAA1199 (mRNA and protein) and clinicopathological parameters were mostly consis-
tent with each other. Another study on GC by Matsuzaki et al was also implicated the
overexpression of KIAA1199 in cancer tissue and the relationship between KIAA1199 and
lymph node metastasis, which was in agreement to our result [13]. Previous studies in other
kinds of cancer also revealed the abnormal expression of KIAA1199 in cancer tissue, such as
breast cancer, colon cancer and pancreatic ductal adenocarcinoma [5,7,10]. Additionally, simi-
lar to our result, the expression of KIAA1199 was also significantly associated with tumor inva-
sion depth, lymph node metastasis and TNM staging, which was demonstrated in clone cancer
study. Furthermore, KIAA1199 was indicated as a prognostic factor and novel therapeutic tar-
get for clone cancer because it was also related to the survival time of patients. These previous
results in clone cancer were partly in consistent with the pathological parameter analysis and
the overall survival rate of GC in this study [4,9,11].
According to the significant changes of clinicopathological parameters, we further explore
the role of KIAA1199 in GC progression. KIAA1199 knockdown reduced cell proliferation,
migration and invasion in NCI-N87 and AGS GC cells. Other related studies revealed that
KIAA1199 could promote cell proliferation, mobility and invasion in breast cancer and colon
cancer by different researchers in recent years [5,11,14]. However, the mechanism of the spe-
cific molecule inducing these biological processes in different cancer is complicated and it still
needs to be further investigated. Several previous reports found KIAA1199 was involved in
EGFR and Wnt signaling pathways in breast cancer, cervical cancer and colon cancer [14,17],
nevertheless, the mechanism of KIAA1199 in GC still remains unknown.
Table 3. Univariate and multivariate Cox regression analysis for overall survival of patients with GC.
Clinicopathological Features Univariate P Multivariate P
Overall survival rate (mean ± S.E) RR 95% CI
KIAA1199 expression 0.000 0.002
Negative 61.795±5.763 0.437(0.261,0.731)
Positive 31.390±4.123
Vascular invasion 0.000 0.017
Absent 65.040 ±5.957 0.506(0.290, 0.885)
Present 31.823 ±4.170
Depth of invasion 0.003 0.045
T1 89.218 ±7.407 0.132(0.018, 0.959)
T2-4 41.212 ±3.784
Lymph node status 0.001 0.776
N0 67.527 ±6.998 0.907(0.0.460,1.789)
N1-3 37.029 ±4.032
Distant metastasis 0.000 0.001
M0 49.548 ±3.981 0.297(0.149,0.589)
M1 9.101 ±2.504
Differentiation 0.221
High 27.120±9.993 - -
High-medium 59.704±14.104
Medium 52.419±8.831
Medium-low 52.914±8.516
Low 38.185±4.562
https://doi.org/10.1371/journal.pone.0175058.t003
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Fig 2. The function of KIAA1199 in NCI-N87 and AGS GC cells. (A) The mRNA expression of KIAA1199 in
different GC cell lines by Realtime-PCR. (B) The mRNA and protein expression of KIAA1199 were
significantly reduced in NCI-N87 and AGS GC cells transfected with sh-KIAA1199, detected by Realtime-
PCR and Western blotting. Sh-control served as the negative control. (C) The MTT proliferation assay and (D)
colony formation assay revealed a growth inhibitory effect of knockdown of KIAA1199 in NCI-N87 and AGS
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In the present study, we detected several typical signaling pathways in GC cells especially
the ones which participated in cell migration and invasion based on the clinicopathological
characteristics. As we all known, β-catenin was an important component in Wnt signaling
pathway. Once β-cateninin the cytoplasm accumulating to a certain content, it then translo-
cated from the cytoplasm to the nucleus where it regulated target genes which were involved
in cell migration, invasion and metastasis. Therefore, the expression level of cytoplasm β-cate-
nin was of importance for its biological functions. The abnormal expression of β-catenin had
been reported to be associated with the development and progression of several types of can-
cers, such as colon cancer, breast cancer, gastric cancer and other malignant tumors [18–20].
Clinicopathological parameters also demonstrated that β-catenin was a risk factor for TNM
staging, distant metastasis and lymph node metastasis [21]. According to our results, knock-
down of KIAA1199 not only resulted in decreased expression of β-catenin, but inhibited the
translocation of β-catenin from cytoplasm to nucleus in GC cells. The decreased expression of
two main downstream targets of Wnt/β-catenin pathway was also detected in KIAA1199
knockdown GC cells in comparison to sh-control cells. These results suggested that KIAA1199
could potentially promote GC cell migration and invasion by the indirect up-regulation of
Wnt/β-catenin pathway. This finding was in agreement to the result that had been reported in
colon cancer, which explained the association of KIAA1199 with cell proliferation [14]. More-
over, EMT is another key factor to promote cancer invasion and metastasis. In recent studies,
one of the unveiled regulatory patterns of various signaling pathways, including Erk, JNK,
Smad, is through the promotion of cell migration and invasion by triggering EMT progression
[22–24]. Wnt/β-catenin pathway was also identified as one of these essential signaling path-
ways. Our results demonstrated that knockdown of KIAA1199 in two GC cells significantly
reduced the expression of four typical EMT-related molecules. It implicated that one pathway
of KIAA1199 induced migration and invasion was related to the EMT progression which
mediated by Wnt/β-catenin pathway. EMT is a complicated biological process and can be
upregulated by various inducers except these signaling pathways mentioned above. In our
study, we found that three MMP family members (MMP2, MMP7 and MMP14) which had
been verified to induce EMT progression in different types of cancer were decreased in two
KIAA1199 knockdown GC cells. This result indicated that another potential mechanism of
KIAA1199 inducing migration and invasion was due to the increased MMPs expression,
which could also promote EMT progression.
Conclusions
In summary, we have identified that KIAA1199 was upregulated in GC tissues and its expres-
sion was significantly correlated with depth of invasion, lymph node metastasis, distant metas-
tasis and TNM staging. In addition, high expression of KIAA1199 correlated with worse
overall survival of GC patients. More importantly, this is the first evidence that comprehen-
sively confirmed the biological effects of KIAA1199 in GC progression, including the accelera-
tion of cell proliferation, migration and invasion. The downstream mechanism of KIAA1199
altering GC cell behaviors is potentially via the activation of EMT progression triggered by
Wnt/β-catenin signaling pathway and MMPs. This is the first study to investigate the impact
GC cells. (E) Knockdown of KIAA1199 reduced wound closure in scratch wounding migration assay in
NCI-N87 and AGS GC cells. Photograghs were taken at 24 and 36 h in NCI-N87 cells, 4 and 8 h in AGS cells.
(F) Knockdown of KIAA1199 decreased migration though Transwell chamber migration assay. (G) KIAA1199
knockdown inhibited the GC cell invasion ability though Transwell chamber invasion assay. The data were
shown as mean ± SD. *P<0.05, **P<0.01,***P<0.001.
https://doi.org/10.1371/journal.pone.0175058.g002
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Fig 3. KIAA1199 induced EMT progression by upregulating Wnt/β-catenin signaling and MMPs in GC
cells. (A) The mRNA and protein expression of β-catenin were significantly reduced in KIAA1199 knockdown
NCI-N87 and AGS GC cells compared with sh-control cells respectively, detected by Realtime-PCR and
Western blotting. (B) The nucleus expression of β-catenin was also decreased in KIAA1199 knockdown
NCI-N87 and AGS GC cells, detected by Western blotting. (C)The expression of c-myc and cyclinD1 was
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of KIAA1199 on important cellular traits of GC cells, and such effect was supported by the
clinical evidence. Several key molecules which closely related to EMT progression and a pro-
found regulatory mechanism of KIAA1199 in GC progression were highlighted as potential
biomarkers or therapeutic targets for GC therapy.
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